National Pharmaceutical Pricing Authority

(Published in Part II, Section 3, Sub Section (ii) of the
Gazette of India Extraordinary)

Government of India
Ministry of Chemicals and Fertilizers
Department of Pharmaceuticals
(National Pharmaceuticals Pricing Authority)

New Delhi, the 20th September, 2013

ORDER

S.O.2876(E) – In compliance of directions given in line the review order passed by the Department of Pharmaceuticals on 19.11.2012 vide letter no. 31015/15/2011-PI.I in respect of S.O. No. 2710(E) dated 28.11.2011 for I.V. Fluids, fixing the prices of Sodium Chloride (0.9%w/v)+ Dextrose (5%w/v) Injection formulations, the matter has been reconsidered and re-examined by the National Pharmaceutical Pricing Authority (hereinafter mentioned as NPPA).

Accordingly, in respect of above mentioned price fixation and in exercise of the powers, conferred by paragraph 10(b) of the Drugs (Prices Control) Order, 1995, read with No. S.O. 637 (E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the NPPA, hereby fixes/revises the prices as specified in column (4) of the table hereto annexed as the retail price/revised retail price, exclusive of excise duty, Sales Taxes/VAT and local taxes, if any, in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the pack size specified in the corresponding entries in column (3) thereof; manufactured by M/s Baxter India Pvt. Ltd.

Table

Sl. No.	Name of the formulation/Strength/Composition	Pack Size	Retail Price without Excise Duty Sales Tax /VAT and Local Tax, if any (Rs.)
(1)	(2)	(3)	(4)
1	Sodium Chloride (0.9%w/v)+ Dextrose (5%w/v) Injection Each 100ml contains Dextrose Anhydrous-5gm Sodium Chloride-900mg Water for Injection q.s.	500 ml Viaflex Container (PVC) with two ports	60.10

Note:

The concerned company may add taxes only if they have paid actually to the Government on the price mentioned in the column (4), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.
The manufacturer / marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the NPPA.
These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
These prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing/marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.
The manufacturer or marketing company not complying with the ceiling prices and conditions specified in notes hereinabove within 15 days from the date of above said notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 1995 read with the EC Act, 1955.

PN/139/7/2013/F

F. No. 8(7)/2013/D.P./NPPA-Div.II

(MANMOHAN KAUR)
Deputy Director
National Pharmaceutical Pricing Authority

Last Page Updated: 24-01-2019

Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)